Who pays for what, how much do they pay, what is it worth, and why does it matter? These questions are important to answer for biotech firms, policymakers, investors, and patients. We're using data to better inform decisions. Our policy expertise is founded in uniting years of working with industry and academic policy analysis. Data sources are constantly being integrated at QualiaBio to help stakeholders evaluate implications and make faster, better informed decisions.